title: 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells.
abstract: Peroxisome proliferator-activated receptor-gamma (PPAR-gamma)is a member of nuclear hormone receptor superfamily, and is knownto play a role in various biological processes including inflammatoryresponses and adipocyte differentiation. CX3CL1/fractalkineis a potent agonist for chemotaxis and adhesion of monocytes and lymphocytes. Endothelial cells produce fractalkine when stimulated with cytokinessuch as interleukin-1 (IL-1), tumour necrosis factor-alpha andinterferon-gamma (IFN-gamma). We herein report that 15-deoxy-n12,14 -prostaglandinJ2 (15d-PGJ2), a PPAR-gamma agonist,inhibits the expression of fractalkine induced by IFN-gamma orIL-1beta in human endothelial cells. Agonist for PPAR-alpha (WY14643)or PPAR-gamma (ciglitazone) did not inhibit the cytokine-inducedfractalkine expression, and the effect of 15d-PGJ2 maybe independent of PPAR. 15-Deoxy-D12,14 prostaglandinJ2 also inhibited the adhesion of blood mononuclear cellsto endothelial monolayers treated with IFN-gamma or IL-1beta. The data suggest that 15d-PGJ2 regulates inflammatoryreactions, at least in part, through the inhibition of fractalkineexpression and leucocyte traffic through the endothelium.
authors.affiliation: Departments of Vascular Biology, Hirosaki University School of Medicine, Japan. timaizum@cc.hirosaki-u.ac.jp
authors.forename: Tadaatsu
authors.initials: T
authors.lastname: Imaizumi
authors.forename: Tomoh
authors.initials: T
authors.lastname: Matsumiya
authors.forename: Wakako
authors.initials: W
authors.lastname: Tamo
authors.forename: Takeo
authors.initials: T
authors.lastname: Shibata
authors.forename: Koji
authors.initials: K
authors.lastname: Fujimoto
authors.forename: Mika
authors.initials: M
authors.lastname: Kumagai
authors.forename: Hidemi
authors.initials: H
authors.lastname: Yoshida
authors.forename: Xue-Fan
authors.initials: XF
authors.lastname: Cui
authors.forename: Kunikazu
authors.initials: K
authors.lastname: Tanji
authors.forename: Masaharu
authors.initials: M
authors.lastname: Hatakeyama
authors.forename: Koichi
authors.initials: K
authors.lastname: Wakabayashi
authors.forename: Kei
authors.initials: K
authors.lastname: Satoh
mesh_terms: D002448:Cell Adhesion / Q000502:physiology; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000096:biosynthesis / Q000235:genetics*; D003513:Cycloheximide / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008565:Membrane Proteins / Q000096:biosynthesis / Q000235:genetics*; D015230:Prostaglandin D2 / Q000031:analogs & derivatives / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D014157:Transcription Factors / Q000819:agonists; D014471:Umbilical Veins / Q000378:metabolism
chemical_list: C097240:15-deoxy-delta(12,14)-prostaglandin J2; C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; D007375:Interleukin-1; D008565:Membrane Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D007371:Interferon-gamma; D003513:Cycloheximide; D015230:Prostaglandin D2